← All trials
NCT02687373
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2016
- Primary completion
- Dec 1, 2017
- Completion date
- Nov 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 572
- Arms / groups
- 30 / —
- Source
- AACT · pre-existing
Sponsors
- Sanaria Inc.Lead sponsor
- Kenya Medical Research InstituteOverall official - principal investigator
- Kenya Medical Research InstituteCollaborator
- University of MarylandCollaborator
- National Institutes of Health (NIH)Collaborator
- Centers for Disease Control and Prevention (CDC)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.